Angelo Gordon & Co’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Angelo Gordon & Co’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,333	Closed	-$135K	–	231
2022 Q4	$135K	Hold	13,333	–	–	0.02%	166
2022 Q3	$132K	Hold	13,333	–	–	0.02%	243
2022 Q2	$131K	Buy	+13,333	New	+$2.26K	0.01%	241

Angelo Gordon & Co's EBACW Position: Q1 2023 in Review

Angelo Gordon & Co sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 13,333 shares — an estimated $135K sold.

Angelo Gordon & Co first reported a position in EBACW in Q2 2022 and held it in 3 quarters. The position peaked at $135K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Angelo Gordon & Co reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Angelo Gordon & Co sold 13,333 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $135K.
Angelo Gordon & Co first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2022 and held it in 3 quarters.
Angelo Gordon & Co's European Biotech Acquisition Corp. Warrant position peaked at $135K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Angelo Gordon & Co's 13F filing for Q1 2023, filed 15 May 2023.